Phosphorylation status of fetuin-A is critical for inhibition of insulin action and is correlated with obesity and insulin resistance

Autor: Laurel A. Littlefield, Suresh T. Mathews, Vishal Kothari, Rebecca A. Ludvigsen, Mary M. Nickles, Peter W. Grandjean, A. Jack Mahurin, Robert L. Bowers, Teayoun Kim, Hilal Zaid, Xiaoming He, James B. Papizan, Guang Ren, Phillip J. Bilan, Carl K. Okerberg, Felipe Araya-Ramirez
Rok vydání: 2019
Předmět:
Zdroj: American Journal of Physiology-Endocrinology and Metabolism. 317:E250-E260
ISSN: 1522-1555
0193-1849
Popis: Fetuin-A (Fet-A), a hepatokine associated with insulin resistance, obesity, and incident type 2 diabetes, is shown to exist in both phosphorylated and dephosphorylated forms in circulation. However, studies on fetuin-A phosphorylation status in insulin-resistant conditions and its functional significance are limited. We demonstrate that serum phosphofetuin-A (Ser312) levels were significantly elevated in high-fat diet-induced obese mice, insulin-resistant Zucker diabetic fatty rats, and in individuals with obesity who are insulin resistant. Unlike serum total fetuin-A, serum phosphofetuin-A was associated with body weight, insulin, and markers of insulin resistance. To characterize potential mechanisms, fetuin-A was purified from Hep3B human hepatoma cells. Hep3B Fet-A was phosphorylated (Ser312) and inhibited insulin-stimulated glucose uptake and glycogen synthesis in L6GLUT4 myoblasts. Furthermore, single (Ser312Ala) and double (Ser312Ala + Ser120Ala) phosphorylation-defective Fet-A mutants were without effect on glucose uptake and glycogen synthesis in L6GLUT4 myoblasts. Together, our studies demonstrate that phosphorylation status of Fet-A (Ser312) is associated with obesity and insulin resistance and raise the possibility that Fet-A phosphorylation may play a role in regulation of insulin action.
Databáze: OpenAIRE